VXRTVaxart, Inc.

About Vaxart, Inc. (VXRT)

Vaxart, Inc. (VXRT) is a Biotechnology company headquartered in South San Francisco, CA, United States whose shares trade over-the-counter on the OTCQX tier.

Vaxart is a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on our innovative delivery platform. We have proprietary technology, partnerships to accelerate our development, and an experienced team with deep industry expertise.

Products and services

At Vaxart, we are revolutionizing how the immune system responds and the way vaccines are delivered with our oral pill vaccine. Our diverse pipeline of prophylactic and therapeutic vaccines targets a range of infectious diseases. We are working to create a new generation of immunizations that are easier to administer, more accessible, and designed to meet the global health challenges now and in the future.

VXRT key facts

Ticker symbol

VXRT

Market tier

OTCQX

Sector

Healthcare

Industry

Biotechnology

Headquarters

South San Francisco, CA, United States

Country of incorporation

US

Year of incorporation

2007

Employees

105

Estimated market cap

$81.45M (as of Aug 1, 2025)

Shares outstanding

228,913,668

Reporting standard

U.S. Reporting: SEC Reporting

Audit status

Audited

Fiscal year end

12/31

Vaxart, Inc. leadership

• Steven Lo — CEO, President
• Jeroen Nicolaas Grasman — CFO
• James F Cummings — CMO
• Sean Tucker — CSO
• Edward Berg — General Counsel, Company Secretary, Senior VP
• Susan Aoki — Controller
• Accounts Payable — Other

Explore more: Biotechnology stocks · Healthcare sector · OTCQX stocks · OTC stocks starting with V